Magnesium in pain control
Phase 3
Recruiting
- Conditions
- Condition 1: Long bone fracture. Condition 2: Investigating the analgesic effect of ketamine. Condition 3: Investigating the analgesic effect of magnesium sulfate + ketamine.
- Registration Number
- IRCT20240318061327N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
All patients with long bone fractures aged 18 to 65 years and weighing between 60 to 80 kg and with a vas scoring pain level of more than 4 out of 10 have referred to the Golestan hospital emergency room, and there was no pain relief intervention before that, including the prescription of any medication. have not had
Exclusion Criteria
Unstable hemodynamics, alcohol consumption, neuromuscular diseases, pregnant and lactating women, high blood pressure (systolic more than 145 mmHg and diastolic more than 100 mmHg), history of benzodiazepine and ketamine use, medical diseases (such as heart failure, liver, kidney, stomach ulcer, cardiac arrhythmia).
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umerical scale of pain intensity. Timepoint: Upon arrival (0) and 5, 15 and 30 minutes. Method of measurement: visual analog scale.
- Secondary Outcome Measures
Name Time Method